Skip to main content
. Author manuscript; available in PMC: 2013 Sep 5.
Published in final edited form as: Cancer Genet Cytogenet. 2010 Dec;203(2):141–148. doi: 10.1016/j.cancergencyto.2010.08.009

Table 5.

Percent of abnormal nuclei reported by each CRC participant for two patients with CLL and a known karyotype or FISH pattern in a proficiency test

Percent 6q- nuclei
 Percent 11q- nuclei
 Percent +12 nuclei
Pt Specimen A B C D E Pt A B C D E Pt A B C D E
1 PB nd 1.5 0.0 0.0 0.0 1 0.0 2.0 0.0 0.0 0.5 1 0.0 graphic file with name nihms493106t15.jpg graphic file with name nihms493106t16.jpg 0.0 1.0
2 PB nd 0.0 0.0 0.0 0.5 2 1.5 0.0 0.0 0.0 1.0 2 66.5 75.5 68.0 70.5 70.0
Percent 13q–x1 nuclei
 Percent 13q–x2 nuclei
 Percent 17p- nuclei
Pt Specimen A B C D E Pt A B C D E Pt A B C D E
1 PB graphic file with name nihms493106t17.jpg 1.5 0.0 0.0 5.0 1 0.0 2.0 0.0 0.0 0.0 1 67.0 57.0 64.0 38.0 56.5
2 PB 54.0 50.0 56.0 56.0 45.5 2 28.0 18.5 23.0 18.5 26.0 2 4.0 0.0 0.0 0.0 1.5
Percent t(14;?) nuclei
Pt Specimen A B C D E
1 PB 0.0 0.0 0.0 0.0 0.0
2 PB 0.0 0.0 0.0 0.0 0.0

graphic file with name nihms493106ig1.jpgFalse positive

graphic file with name nihms493106ig2.jpgFalse negative

Abbreviations: ND, not done; PB, peripheral blood; Pt, patient.

Participants used their own FISH probes and methods to obtain these results.